Exploring the relationship between co-abundance of gut microbiota and novel metabolic pathways in different subtypes of irritable bowel syndrome: insights from the American Gut Project.

Front Med (Lausanne) · 2025 · PMC12321851 · PMID 40766067

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Consequently, we primarily analyzed the predicted pathway abundance changes of tryptophan metabolic pathways ( Figures 8E , F ), which demonstrated a decreasing trend in IBS-U, but the difference was not statistically significant.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.